# Piperacillin and Tazobactam

NDC: 65219-256
Generic name: Piperacillin and Tazobactam
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20171116

FDA application: ANDA203720

## Active ingredients

- PIPERACILLIN SODIUM: 36 g/180mL
- TAZOBACTAM SODIUM: 4.5 g/180mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-256"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-256
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a894b94-171f-4217-81a2-0e84796b0b41